Dr Reddys unveils Methylphenidate Hydrochloride ER Tablets in US
Concerta is indicated to treat attention deficit hyperactivity disorder(ADHD).
Hyderabad: Dr. Reddys Laboratories Ltd. on Thursday announced the launch of Methylphenidate Hydrochloride Extended-Release Tablets USP, a therapeutic equivalent generic version of Concerta, in various strengths, in the USA market.
The drug was approved by the U.S. Food and Drug Administration (USFDA), a press release from the drug maker said.
Concerta is indicated to treat attention deficit hyperactivity disorder (ADHD).
Dr. Reddys Methylphenidate Hydrochloride Extended- Release Tablets, USP are available in strengths of 18 mg, 27 mg, 36 mg, and 54 mg tablets in bottle count sizes of 100, it said.